Rebuilding a sports brand's core range
Five products in production from late 2023
At a glance
- Capsules and a powder
- TGA-listed medicines and food
- Includes Testofen®, a clinically studied fenugreek extract
- Five products, reformulation to reorder
The brand
A private-equity-backed Australian sports and wellness brand, turning over A$24 million a year by 2019 and exporting to New Zealand, the UK and the UAE.
The challenge
Several of its best-known formulas had room to improve on ingredient quality, dose and permitted indications.
What we built
Four TGA-listed capsules, reformulated from scratch (one built on Testofen®, a clinically studied fenugreek extract), plus a food-pathway performance powder. We handled the TGA listings, stability protocols, label review and manufacturing.
Manufacturing and delivery
We managed manufacturing for all five products and every reorder, and worked through a co-packer delay, through to delivery.
The result
- Five products in production from late 2023
- Reorders on three of them within a year
Related case studies
Related case studies
Nine products and a long partnership
Five production batches from 2021 to 2025
Read the story →
Practitioner-grade natural medicine, built on clinical evidence
A brand in practitioner clinics and premium retailers across Australia and New Zealand, a member of 1% for the Planet, and expanding into new markets.
Read the story →
A hair care brand that keeps coming back
Working together since 2021
Read the story →Fifteen minutes on your pipeline. No deck, no obligation.
